Robert J. Schneider, Ph.D. - Publications

Affiliations: 
2011 Harvard University, Cambridge, MA, United States 

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Elias HK, Spevak C, Kannan L, Ali MA, Martin GH, Selvaraj S, Eng WS, Zhao G, Ernlund A, Rajasekhar V, Woolthuis CM, Schneider RJ, Park CY. Unique Regulatory Pathways Dictate the Translational Program in Hematopoietic Stem and Progenitor Cells Blood. 134: 1180-1180. DOI: 10.1182/Blood-2019-131333  0.305
2018 Rios-Fuller TJ, Ortiz-Soto G, Lacourt-Ventura M, Maldonado-Martinez G, Cubano LA, Schneider RJ, Martinez-Montemayor MM. extract (GLE) impairs breast cancer stem cells by targeting the STAT3 pathway. Oncotarget. 9: 35907-35921. PMID 30542507 DOI: 10.18632/Oncotarget.26294  0.304
2018 Robichaud N, Sonenberg N, Ruggero D, Schneider RJ. Translational Control in Cancer. Cold Spring Harbor Perspectives in Biology. PMID 29959193 DOI: 10.1101/Cshperspect.A032896  0.3
2017 Geter PA, Ernlund AW, Bakogianni S, Alard A, Arju R, Giashuddin S, Gadi A, Bromberg J, Schneider RJ. Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming. Genes & Development. 31: 2235-2249. PMID 29269484 DOI: 10.1101/Gad.305631.117  0.3
2015 de la Parra C, Borrero-Garcia LD, Cruz-Collazo A, Schneider RJ, Dharmawardhane S. Equol, an isoflavone metabolite, regulates cancer cell viability and protein synthesis initiation via c-Myc and eIF4G. The Journal of Biological Chemistry. 290: 6047-57. PMID 25593313 DOI: 10.1074/Jbc.M114.617415  0.321
2015 Volta V, Ernlund A, Valeta A, Demaria S, Schneider RJ. MTOR inhibition favors the differentiation of human in vitro-induced regulatory T cell through selective protein synthesis Journal For Immunotherapy of Cancer. 3: 79. DOI: 10.1186/2051-1426-3-S2-P79  0.324
2015 Alard A, Musa F, Schneider R. Abstract 2262: Evidence that the translational initiation factor DAP5 plays a critical role in breast cancer metastasis Cancer Research. 75: 2262-2262. DOI: 10.1158/1538-7445.Am2015-2262  0.319
2014 Musa F, Alard A, David-West G, Giuroiu I, Blank S, Pothuri B, Curtin JP, Schneider R. Abstract 4525: mTOR complex inhibition as a novel therapeutic strategy in high-grade papillary serous ovarian cancer Cancer Research. 74: 4525-4525. DOI: 10.1158/1538-7445.Am2014-4525  0.305
2013 Pola C, Formenti SC, Schneider RJ. Vitronectin-αvβ3 integrin engagement directs hypoxia-resistant mTOR activity and sustained protein synthesis linked to invasion by breast cancer cells. Cancer Research. 73: 4571-8. PMID 23722547 DOI: 10.1158/0008-5472.Can-13-0218  0.321
2013 Suarez-Arroyo IJ, Rosario-Acevedo R, Aguilar-Perez A, Clemente PL, Cubano LA, Serrano J, Schneider RJ, Martínez-Montemayor MM. Anti-tumor effects of Ganoderma lucidum (reishi) in inflammatory breast cancer in in vivo and in vitro models. Plos One. 8: e57431. PMID 23468988 DOI: 10.1371/Journal.Pone.0057431  0.326
2012 Schneider RJ, Perrin DP, Vasilyev NV, Marx GR, del Nido PJ, Howe RD. Mitral annulus segmentation from four-dimensional ultrasound using a valve state predictor and constrained optical flow. Medical Image Analysis. 16: 497-504. PMID 22200622 DOI: 10.1016/J.Media.2011.11.006  0.737
2012 Schneider RJ, Perrin DP, Vasilyev NV, Marx GR, Del Nido PJ, Howe RD. Real-time image-based rigid registration of three-dimensional ultrasound. Medical Image Analysis. 16: 402-14. PMID 22154960 DOI: 10.1016/J.Media.2011.10.004  0.724
2012 Silvera D, Connolly E, Volta V, Arju R, Venuto T, Schneider R. Abstract P5-03-02: Targeting mRNA Translation to Enhance the Radiosensitivity of Inflammatory Breast Cancer Stem Cells Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P5-03-02  0.327
2011 Tenenholtz NA, Hammer PE, Schneider RJ, Vasilyev NV, Howe RD. On the Design of an Interactive, Patient-Specific Surgical Simulator for Mitral Valve Repair. Proceedings of the ... Ieee/Rsj International Conference On Intelligent Robots and Systems. Ieee/Rsj International Conference On Intelligent Robots and Systems. 2011: 1327-1332. PMID 24511427 DOI: 10.1109/IROS.2011.6048851  0.747
2011 Schneider RJ, Tenenholtz NA, Perrin DP, Marx GR, del Nido PJ, Howe RD. Patient-specific mitral leaflet segmentation from 4D ultrasound. Medical Image Computing and Computer-Assisted Intervention : Miccai ... International Conference On Medical Image Computing and Computer-Assisted Intervention. 14: 520-7. PMID 22003739 DOI: 10.1007/978-3-642-23626-6_64  0.741
2011 Singh J, Stein S, Volm M, Smith J, Novik Y, Speyer J, Adams S, Meyers M, Muggia F, Schneider R, Formenti S, Omene C, Choi H, Davis S, Goldberg J, et al. P1-17-07: Phase II Trial of RAD001 Plus Carboplatin in Patients with Triple-Negative Metastatic Breast Cancer. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P1-17-07  0.301
2011 Schneider RJ, Burke WC, Marx GR, Del Nido PJ, Howe RD. Modeling mitral valve leaflets from three-dimensional ultrasound Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 6666: 215-222. DOI: 10.1007/978-3-642-21028-0_27  0.511
2010 Schneider RJ, Perrin DP, Vasilyev NV, Marx GR, del Nido PJ, Howe RD. Mitral annulus segmentation from 3D ultrasound using graph cuts. Ieee Transactions On Medical Imaging. 29: 1676-87. PMID 20562042 DOI: 10.1109/Tmi.2010.2050595  0.733
2010 Silvera D, Formenti SC, Schneider RJ. Translational control in cancer. Nature Reviews. Cancer. 10: 254-66. PMID 20332778 DOI: 10.1038/Nrc2824  0.301
2009 Schneider RJ, Perrin DP, Vasilyev NV, Marx GR, Del Nido PJ, Howe RD. Mitral Annulus Segmentation from Three-Dimensional Ultrasound. Proceedings / Ieee International Symposium On Biomedical Imaging: From Nano to Macro. Ieee International Symposium On Biomedical Imaging. 779-782. PMID 22011812 DOI: 10.1109/ISBI.2009.5193165  0.723
2009 Cuesta R, Gupta M, Schneider RJ. The regulation of protein synthesis in cancer. Progress in Molecular Biology and Translational Science. 90: 255-92. PMID 20374744 DOI: 10.1016/S1877-1173(09)90007-2  0.306
2009 Silvera D, Schneider RJ. Inflammatory breast cancer cells are constitutively adapted to hypoxia. Cell Cycle (Georgetown, Tex.). 8: 3091-6. PMID 19755858 DOI: 10.4161/Cc.8.19.9637  0.321
2009 Silvera D, Arju R, Darvishian F, Levine PH, Zolfaghari L, Goldberg J, Hochman T, Formenti SC, Schneider RJ. Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer. Nature Cell Biology. 11: 903-8. PMID 19525934 DOI: 10.1038/Ncb1900  0.307
2008 Ramírez-Valle F, Braunstein S, Zavadil J, Formenti SC, Schneider RJ. eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy. The Journal of Cell Biology. 181: 293-307. PMID 18426977 DOI: 10.1083/Jcb.200710215  0.308
2007 Braunstein S, Karpisheva K, Pola C, Goldberg J, Hochman T, Yee H, Cangiarella J, Arju R, Formenti SC, Schneider RJ. A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer. Molecular Cell. 28: 501-12. PMID 17996713 DOI: 10.1016/J.Molcel.2007.10.019  0.306
2007 Schneider RJ, Sonenberg N. 15 Translational Control in Cancer Development and Progression Cold Spring Harbor Monograph Archive. 48: 401-431. DOI: 10.1101/087969767.48.401  0.312
2005 Schneider R, Braunstein S, Xi Q, Formenti S. Ionizing Radiation Controls Protein Synthesis Through a Novel Akt-independent Pathway Involving Regulation of mTOR and 4E-BP1 Stability International Journal of Radiation Oncology Biology Physics. 63. DOI: 10.1016/J.Ijrobp.2005.07.249  0.303
Show low-probability matches.